BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kirsch IR, Watanabe R, O'Malley JT, Williamson DW, Scott LL, Elco CP, Teague JE, Gehad A, Lowry EL, LeBoeuf NR, Krueger JG, Robins HS, Kupper TS, Clark RA. TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci Transl Med 2015;7:308ra158. [PMID: 26446955 DOI: 10.1126/scitranslmed.aaa9122] [Cited by in Crossref: 105] [Cited by in F6Publishing: 87] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Wong GK, Heather JM, Barmettler S, Cobbold M. Immune dysregulation in immunodeficiency disorders: The role of T-cell receptor sequencing. J Autoimmun 2017;80:1-9. [PMID: 28400082 DOI: 10.1016/j.jaut.2017.04.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
2 Ghazawi FM, Litvinov IV. Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada: A Response to a Letter. J Cutan Med Surg 2018;22:657-8. [DOI: 10.1177/1203475418786215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
3 Roelens M, Delord M, Ram-Wolff C, Marie-Cardine A, Alberdi A, Maki G, Homyrda L, Bensussan A, Bagot M, Toubert A, Moins-Teisserenc H. Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity. Blood 2017;130:1468-71. [PMID: 28760889 DOI: 10.1182/blood-2017-03-772996] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
4 Berg S, Villasenor-Park J, Haun P, Kim EJ. Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome. Curr Hematol Malig Rep 2017;12:234-43. [PMID: 28540671 DOI: 10.1007/s11899-017-0387-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 de Masson A, O'Malley JT, Elco CP, Garcia SS, Divito SJ, Lowry EL, Tawa M, Fisher DC, Devlin PM, Teague JE, Leboeuf NR, Kirsch IR, Robins H, Clark RA, Kupper TS. High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides. Sci Transl Med 2018;10:eaar5894. [PMID: 29743350 DOI: 10.1126/scitranslmed.aar5894] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 25.5] [Reference Citation Analysis]
6 Kaemmerer T, Stadler PC, Helene Frommherz L, Guertler A, Einar French L, Reinholz M. Alitretinoin in the treatment of cutaneous T-cell lymphoma. Cancer Med 2021;10:7071-8. [PMID: 34435474 DOI: 10.1002/cam4.4237] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 LeBlanc RE, Tavallaee M, Kim YH, Kim J. Useful Parameters for Distinguishing Subcutaneous Panniculitis-like T-Cell Lymphoma From Lupus Erythematosus Panniculitis. Am J Surg Pathol 2016;40:745-54. [PMID: 26796503 DOI: 10.1097/PAS.0000000000000596] [Cited by in Crossref: 41] [Cited by in F6Publishing: 11] [Article Influence: 10.3] [Reference Citation Analysis]
8 Chen C, Chang K, Medeiros LJ, Lee JY. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation: Hydroa vacciniforme (HV) and HV-like T-cell lymphoma. J Cutan Pathol 2016;43:1102-11. [DOI: 10.1111/cup.12801] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
9 Dulmage B, Geskin L, Guitart J, Akilov OE. The biomarker landscape in mycosis fungoides and Sézary syndrome. Exp Dermatol 2017;26:668-76. [PMID: 27897325 DOI: 10.1111/exd.13261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
10 Hawkes JE, Gonzalez JA, Krueger JG. Autoimmunity in Psoriasis: Evidence for Specific Autoantigens. Curr Derm Rep 2017;6:104-12. [DOI: 10.1007/s13671-017-0177-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Padovan E. Modulation of CD4+ T Helper Cell Memory Responses in the Human Skin. Int Arch Allergy Immunol 2017;173:121-37. [PMID: 28787717 DOI: 10.1159/000477728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
12 Tu AA, Gierahn TM, Monian B, Morgan DM, Mehta NK, Ruiter B, Shreffler WG, Shalek AK, Love JC. TCR sequencing paired with massively parallel 3' RNA-seq reveals clonotypic T cell signatures. Nat Immunol 2019;20:1692-9. [PMID: 31745340 DOI: 10.1038/s41590-019-0544-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
13 Lefrançois P, Tetzlaff MT, Moreau L, Watters AK, Netchiporouk E, Provost N, Gilbert M, Ni X, Sasseville D, Duvic M, Litvinov IV. TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform. Front Med (Lausanne) 2017;4:153. [PMID: 29018799 DOI: 10.3389/fmed.2017.00153] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
14 Larocca CA, LeBoeuf NR. Overview of Cutaneous T-Cell Lymphomas. Hematol Oncol Clin North Am 2019;33:669-86. [PMID: 31229162 DOI: 10.1016/j.hoc.2019.04.004] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Peterson E, Weed J, Lo Sicco K, Latkowski JA. Cutaneous T Cell Lymphoma: A Difficult Diagnosis Demystified. Dermatol Clin 2019;37:455-69. [PMID: 31466586 DOI: 10.1016/j.det.2019.05.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
16 Ollila TA, Sahin I, Olszewski AJ. Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma. Onco Targets Ther 2019;12:1085-94. [PMID: 30799938 DOI: 10.2147/OTT.S165615] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 12.5] [Reference Citation Analysis]
17 Jiang G, Shen X, Kang H, Li K, Zheng J, Yu Y. Serum metabolite profiling of cutaneous T-cell lymphoma based on a multiplatform approach. J Chromatogr B Analyt Technol Biomed Life Sci 2018;1077-1078:71-6. [PMID: 29413580 DOI: 10.1016/j.jchromb.2018.01.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
18 Vega F, Medeiros LJ. A suggested immunohistochemical algorithm for the classification of T-cell lymphomas involving lymph nodes. Hum Pathol 2020;102:104-16. [PMID: 32479842 DOI: 10.1016/j.humpath.2020.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Villani AP, Rozieres A, Bensaid B, Eriksson KK, Mosnier A, Albert F, Mutez V, Brassard O, Baysal T, Tardieu M, Allatif O, Fusil F, Andrieu T, Jullien D, Dubois V, Giannoli C, Gruffat H, Pallardy M, Cosset FL, Nosbaum A, Kanagawa O, Maryanski JL, Yerly D, Nicolas JF, Vocanson M. Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis. Sci Adv 2021;7:eabe0013. [PMID: 33741590 DOI: 10.1126/sciadv.abe0013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Buus TB, Willerslev-Olsen A, Fredholm S, Blümel E, Nastasi C, Gluud M, Hu T, Lindahl LM, Iversen L, Fogh H, Gniadecki R, Litvinov IV, Persson JL, Bonefeld CM, Geisler C, Christensen JP, Krejsgaard T, Litman T, Woetmann A, Ødum N. Single-cell heterogeneity in Sézary syndrome. Blood Adv 2018;2:2115-26. [PMID: 30139925 DOI: 10.1182/bloodadvances.2018022608] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 18.0] [Reference Citation Analysis]
21 Borcherding N, Voigt AP, Liu V, Link BK, Zhang W, Jabbari A. Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression. Clin Cancer Res 2019;25:2996-3005. [PMID: 30718356 DOI: 10.1158/1078-0432.CCR-18-3309] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 16.0] [Reference Citation Analysis]
22 Lay L, Stroup B, Payton JE. Validation and interpretation of IGH and TCR clonality testing by Ion Torrent S5 NGS for diagnosis and disease monitoring in B and T cell cancers. Pract Lab Med 2020;22:e00191. [PMID: 33304977 DOI: 10.1016/j.plabm.2020.e00191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
23 Radpour R, Forouharkhou F. Single-cell analysis of tumors: Creating new value for molecular biomarker discovery of cancer stem cells and tumor-infiltrating immune cells. World J Stem Cells 2018; 10(11): 160-171 [PMID: 30631391 DOI: 10.4252/wjsc.v10.i11.160] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
24 Oon ML, Lim JQ, Lee B, Leong SM, Soon GS, Wong ZW, Lim EH, Li Z, Yeoh AEJ, Chen S, Ban KHK, Chung TH, Tan SY, Chuang SS, Kato S, Nakamura S, Takahashi E, Ho YH, Khoury JD, Au-Yeung RKH, Cheng CL, Lim ST, Chng WJ, Tripodo C, Rotzschke O, Ong CK, Ng SB. T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor Genes. Cancers (Basel) 2021;13:340. [PMID: 33477749 DOI: 10.3390/cancers13020340] [Reference Citation Analysis]
25 Raghavan SS, Wang JY, Gru AA, Marqueling AL, Teng JMC, Brown RA, Novoa RA, Kim Y, Zehnder J, Zhang BM, Rieger KE. Next-generation sequencing confirms T-cell clonality in a subset of pediatric pityriasis lichenoides. J Cutan Pathol 2021. [PMID: 34614220 DOI: 10.1111/cup.14143] [Reference Citation Analysis]
26 Fanok MH, Sun A, Fogli LK, Narendran V, Eckstein M, Kannan K, Dolgalev I, Lazaris C, Heguy A, Laird ME, Sundrud MS, Liu C, Kutok J, Lacruz RS, Latkowski JA, Aifantis I, Ødum N, Hymes KB, Goel S, Koralov SB. Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma. J Invest Dermatol 2018;138:1116-25. [PMID: 29128259 DOI: 10.1016/j.jid.2017.10.028] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
27 Iyer A, Hennessey D, O'Keefe S, Patterson J, Wang W, Salopek T, Wong GK, Gniadecki R. Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing. Blood Adv 2019;3:1175-84. [PMID: 30967393 DOI: 10.1182/bloodadvances.2018027482] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
28 Zanelli M, Ricci S, Sanguedolce F, Palicelli A, Farnetti E, Tafuni A, Zizzo M, Valli R, Celis MIA, Cavazza A, Longo C, Ascani S. Cutaneous Localization of Classic Hodgkin Lymphoma Associated with Mycosis Fungoides: Report of a Rare Event and Review of the Literature. Life (Basel) 2021;11:1069. [PMID: 34685440 DOI: 10.3390/life11101069] [Reference Citation Analysis]
29 Schneider-Hohendorf T, Mohan H, Bien CG, Breuer J, Becker A, Görlich D, Kuhlmann T, Widman G, Herich S, Elpers C, Melzer N, Dornmair K, Kurlemann G, Wiendl H, Schwab N. CD8(+) T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing. Nat Commun 2016;7:11153. [PMID: 27040081 DOI: 10.1038/ncomms11153] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 10.4] [Reference Citation Analysis]
30 Vieyra-Garcia P, Crouch JD, O'Malley JT, Seger EW, Yang CH, Teague JE, Vromans AM, Gehad A, Win TS, Yu Z, Lowry EL, Na JI, Rook AH, Wolf P, Clark RA. Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma. JCI Insight 2019;4:124233. [PMID: 30626755 DOI: 10.1172/jci.insight.124233] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
31 Lennon NJ, Adalsteinsson VA, Gabriel SB. Technological considerations for genome-guided diagnosis and management of cancer. Genome Med 2016;8:112. [PMID: 27784341 DOI: 10.1186/s13073-016-0370-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
32 Litvinov IV, Tetzlaff MT, Thibault P, Gangar P, Moreau L, Watters AK, Netchiporouk E, Pehr K, Prieto VG, Rahme E, Provost N, Gilbert M, Sasseville D, Duvic M. Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators. Oncoimmunology 2017;6:e1306618. [PMID: 28638728 DOI: 10.1080/2162402X.2017.1306618] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
33 Devata S, Wilcox RA. Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents. Am J Clin Dermatol 2016;17:225-37. [DOI: 10.1007/s40257-016-0177-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
34 Christley S, Scarborough W, Salinas E, Rounds WH, Toby IT, Fonner JM, Levin MK, Kim M, Mock SA, Jordan C, Ostmeyer J, Buntzman A, Rubelt F, Davila ML, Monson NL, Scheuermann RH, Cowell LG. VDJServer: A Cloud-Based Analysis Portal and Data Commons for Immune Repertoire Sequences and Rearrangements. Front Immunol 2018;9:976. [PMID: 29867956 DOI: 10.3389/fimmu.2018.00976] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 9.7] [Reference Citation Analysis]
35 Cui JH, Lin KR, Yuan SH, Jin YB, Chen XP, Su XK, Jiang J, Pan YM, Mao SL, Mao XF, Luo W. TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer. Front Immunol 2018;9:2729. [PMID: 30524447 DOI: 10.3389/fimmu.2018.02729] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 16.0] [Reference Citation Analysis]
36 Wang JY, Hirotsu KE, Neal TM, Raghavan SS, Kwong BY, Khodadoust MS, Brown RA, Novoa RA, Kim YH, Rieger KE. Histopathologic Characterization of Mogamulizumab-associated Rash. Am J Surg Pathol 2020;44:1666-76. [PMID: 32976123 DOI: 10.1097/PAS.0000000000001587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Hodak E, Amitay-laish I. Mycosis fungoides: A great imitator. Clinics in Dermatology 2019;37:255-67. [DOI: 10.1016/j.clindermatol.2019.01.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
38 Khodadoust MS, Olsson N, Wagar LE, Haabeth OA, Chen B, Swaminathan K, Rawson K, Liu CL, Steiner D, Lund P, Rao S, Zhang L, Marceau C, Stehr H, Newman AM, Czerwinski DK, Carlton VE, Moorhead M, Faham M, Kohrt HE, Carette J, Green MR, Davis MM, Levy R, Elias JE, Alizadeh AA. Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens. Nature. 2017;543:723-727. [PMID: 28329770 DOI: 10.1038/nature21433] [Cited by in Crossref: 151] [Cited by in F6Publishing: 132] [Article Influence: 37.8] [Reference Citation Analysis]
39 Amezcua Vesely MC, Pallis P, Bielecki P, Low JS, Zhao J, Harman CCD, Kroehling L, Jackson R, Bailis W, Licona-Limón P, Xu H, Iijima N, Pillai PS, Kaplan DH, Weaver CT, Kluger Y, Kowalczyk MS, Iwasaki A, Pereira JP, Esplugues E, Gagliani N, Flavell RA. Effector TH17 Cells Give Rise to Long-Lived TRM Cells that Are Essential for an Immediate Response against Bacterial Infection. Cell 2019;178:1176-1188.e15. [PMID: 31442406 DOI: 10.1016/j.cell.2019.07.032] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 42.0] [Reference Citation Analysis]
40 Hu-Lieskovan S, Bhaumik S, Dhodapkar K, Grivel JJB, Gupta S, Hanks BA, Janetzki S, Kleen TO, Koguchi Y, Lund AW, Maccalli C, Mahnke YD, Novosiadly RD, Selvan SR, Sims T, Zhao Y, Maecker HT. SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery. J Immunother Cancer 2020;8:e000705. [PMID: 33268350 DOI: 10.1136/jitc-2020-000705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
41 Nielsen SCA, Boyd SD. Human adaptive immune receptor repertoire analysis-Past, present, and future. Immunol Rev 2018;284:9-23. [PMID: 29944765 DOI: 10.1111/imr.12667] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 14.5] [Reference Citation Analysis]
42 Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang SC, Marquardt N, Gibbs A, Detlofsson E, Introini A, Forkel M, Höög C, Tjernlund A, Michaëlsson J, Folkersen L, Mjösberg J, Blomqvist L, Ehrström M, Ståhle M, Bryceson YT, Eidsmo L. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity 2017;46:287-300. [PMID: 28214226 DOI: 10.1016/j.immuni.2017.01.009] [Cited by in Crossref: 249] [Cited by in F6Publishing: 249] [Article Influence: 62.3] [Reference Citation Analysis]
43 Dummer R, Vermeer MH, Scarisbrick JJ, Kim YH, Stonesifer C, Tensen CP, Geskin LJ, Quaglino P, Ramelyte E. Cutaneous T cell lymphoma. Nat Rev Dis Primers 2021;7:61. [PMID: 34446710 DOI: 10.1038/s41572-021-00296-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 De Simone M, Rossetti G, Pagani M. Single Cell T Cell Receptor Sequencing: Techniques and Future Challenges. Front Immunol. 2018;9:1638. [PMID: 30072991 DOI: 10.3389/fimmu.2018.01638] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 23.3] [Reference Citation Analysis]
45 Le Y, Shen X, Kang H, Wang Q, Li K, Zheng J, Yu Y. Accelerated, untargeted metabolomics analysis of cutaneous T-cell lymphoma reveals metabolic shifts in plasma and tumor adjacent skins of xenograft mice. J Mass Spectrom 2018;53:172-82. [DOI: 10.1002/jms.4048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
46 Moyal L, Gorovitz‐haris B, Yehezkel S, Jacob‐hirsch J, Bershtein V, Barzilai A, Rotem C, Sherman S, Amitay‐laish I, Feinmesser M, Hodak E. Unilesional mycosis fungoides is associated with increased expression of micro RNA ‐17~92 and T helper 1 skewing. Br J Dermatol 2019;180:1123-34. [DOI: 10.1111/bjd.17425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Shen X, Wang B, Li K, Wang L, Zhao X, Xue F, Shi R, Zheng J. MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma. J Invest Dermatol 2018;138:2024-32. [PMID: 29559342 DOI: 10.1016/j.jid.2018.03.1500] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
48 Paul S, Pearlman AH, Douglass J, Mog BJ, Hsiue EH, Hwang MS, DiNapoli SR, Konig MF, Brown PA, Wright KM, Sur S, Gabelli SB, Li Y, Ghiaur G, Pardoll DM, Papadopoulos N, Bettegowda C, Kinzler KW, Zhou S, Vogelstein B. TCR β chain-directed bispecific antibodies for the treatment of T cell cancers. Sci Transl Med 2021;13:eabd3595. [PMID: 33649188 DOI: 10.1126/scitranslmed.abd3595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
49 Cocks M, Porcu P, Wick MR, Gru AA. Recent Advances in Cutaneous T-cell Lymphoma. Surgical Pathology Clinics 2019;12:783-803. [DOI: 10.1016/j.path.2019.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
50 Kirsch I, Vignali M, Robins H. T-cell receptor profiling in cancer. Mol Oncol 2015;9:2063-70. [PMID: 26404496 DOI: 10.1016/j.molonc.2015.09.003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 69] [Article Influence: 15.2] [Reference Citation Analysis]
51 Larocca C, Kupper T. Mycosis Fungoides and Sézary Syndrome: An Update. Hematol Oncol Clin North Am 2019;33:103-20. [PMID: 30497668 DOI: 10.1016/j.hoc.2018.09.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
52 Brown SD, Hapgood G, Steidl C, Weng AP, Savage KJ, Holt RA. Defining the clonality of peripheral T cell lymphomas using RNA-seq. Bioinformatics 2017;33:1111-5. [PMID: 28003262 DOI: 10.1093/bioinformatics/btw810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
53 Durgin JS, Weiner DM, Wysocka M, Rook AH. The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication. J Am Acad Dermatol 2021;84:587-95. [PMID: 33352267 DOI: 10.1016/j.jaad.2020.12.027] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Matos TR, de Rie MA, Teunissen MBM. Research Techniques Made Simple: High-Throughput Sequencing of the T-Cell Receptor. J Invest Dermatol 2017;137:e131-8. [PMID: 28532760 DOI: 10.1016/j.jid.2017.04.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
55 Comfere N, Sundram U, Hurley MY, Swick B. Views of dermatopathologists about clonality assays in the diagnosis of cutaneous T-cell and B-cell lymphoproliferative disorders. J Cutan Pathol 2018;45:39-47. [DOI: 10.1111/cup.13072] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
56 Rieger KE, Kim J, Kim YH. Zosteriform Mycosis Fungoides: A New Clinical Presentation With a Dermatomal Distribution. Am J Dermatopathol 2017;39:e17-8. [PMID: 28134736 DOI: 10.1097/DAD.0000000000000652] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
57 Rindler K, Bauer WM, Jonak C, Wielscher M, Shaw LE, Rojahn TB, Thaler FM, Porkert S, Simonitsch-Klupp I, Weninger W, Mayerhoefer ME, Farlik M, Brunner PM. Single-Cell RNA Sequencing Reveals Tissue Compartment-Specific Plasticity of Mycosis Fungoides Tumor Cells. Front Immunol 2021;12:666935. [PMID: 33968070 DOI: 10.3389/fimmu.2021.666935] [Reference Citation Analysis]
58 Querfeld C, Thompson JA, Taylor MH, DeSimone JA, Zain JM, Shustov AR, Johns C, McCann S, Lin GHY, Petrova PS, Uger RA, Molloy N, Shou Y, Akilov OE. Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study. Lancet Haematol 2021;8:e808-17. [PMID: 34627593 DOI: 10.1016/S2352-3026(21)00271-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Alsayyah A. Is it mycosis fungoides? A comprehensive guide to reaching the diagnosis and avoiding common pitfalls. Ann Diagn Pathol 2020;47:151546. [PMID: 32554312 DOI: 10.1016/j.anndiagpath.2020.151546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Miyagaki T. Diagnosis of Early Mycosis Fungoides. Diagnostics (Basel) 2021;11:1721. [PMID: 34574062 DOI: 10.3390/diagnostics11091721] [Reference Citation Analysis]
61 Nicolay JP, Felcht M, Schledzewski K, Goerdt S, Géraud C. Sézary syndrome: old enigmas, new targets. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2016;14:256-64. [DOI: 10.1111/ddg.12900] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
62 Bagherani N, Smoller BR. An overview of cutaneous T cell lymphomas. F1000Res 2016;5:F1000 Faculty Rev-1882. [PMID: 27540476 DOI: 10.12688/f1000research.8829.1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
63 Nosirov B, Billaud J, Vandenbon A, Diez D, Wijaya E, Ishii KJ, Teraguchi S, Standley DM. Mapping circulating serum miRNAs to their immune-related target mRNAs. Adv Appl Bioinform Chem 2017;10:1-9. [PMID: 28203094 DOI: 10.2147/AABC.S121598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
64 Manso R, Martínez-Magunacelaya N, Eraña-Tomás I, Monsalvez V, Rodríguez-Peralto JL, Ortiz-Romero PL, Santonja C, Cristóbal I, Piris MA, Rodríguez-Pinilla SM. Mycosis fungoides progression could be regulated by microRNAs. PLoS One 2018;13:e0198477. [PMID: 29894486 DOI: 10.1371/journal.pone.0198477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Rea B, Haun P, Emerson R, Vignali M, Farooqi M, Samimi S, Elenitsas R, Kirsch I, Bagg A. Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma. J Clin Pathol 2018;71:814-20. [DOI: 10.1136/jclinpath-2018-205004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
66 Walia R, Yeung CCS. An Update on Molecular Biology of Cutaneous T Cell Lymphoma. Front Oncol 2019;9:1558. [PMID: 32039026 DOI: 10.3389/fonc.2019.01558] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
67 Koch H, Starenki D, Cooper SJ, Myers RM, Li Q. powerTCR: A model-based approach to comparative analysis of the clone size distribution of the T cell receptor repertoire. PLoS Comput Biol 2018;14:e1006571. [PMID: 30485278 DOI: 10.1371/journal.pcbi.1006571] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
68 O'Malley JT, de Masson A, Lowry EL, Giobbie-Hurder A, LeBoeuf NR, Larocca C, Gehad A, Seger E, Teague JE, Fisher DC, Kupper TS, Devlin PM, Clark RA. Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides. Clin Cancer Res 2020;26:408-18. [PMID: 31636100 DOI: 10.1158/1078-0432.CCR-18-4147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
69 Vieyra-Garcia P, Wolf P. Psoralen-ultraviolet A maintenance in mycosis fungoides: the underlying question. Br J Dermatol 2017;177:336-7. [PMID: 28833012 DOI: 10.1111/bjd.15670] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Cyrenne BM, Lewis JM, Weed JG, Carlson KR, Mirza FN, Foss FM, Girardi M. Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients. Blood 2017;130:2073-83. [PMID: 28972015 DOI: 10.1182/blood-2017-06-792150] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
71 Vieyra-Garcia P, Fink-Puches R, Porkert S, Lang R, Pöchlauer S, Ratzinger G, Tanew A, Selhofer S, Paul-Gunther S, Hofer A, Gruber-Wackernagel A, Legat F, Patra V, Quehenberger F, Cerroni L, Clark R, Wolf P. Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial. JAMA Dermatol 2019;155:538-47. [PMID: 30892603 DOI: 10.1001/jamadermatol.2018.5905] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 21.0] [Reference Citation Analysis]
72 Stadler R, Stranzenbach R. Molecular pathogenesis of cutaneous lymphomas. Exp Dermatol 2018;27:1078-83. [DOI: 10.1111/exd.13701] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
73 Brunner PM, Emerson RO, Tipton C, Garcet S, Khattri S, Coats I, Krueger JG, Guttman-yassky E. Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues. Allergy 2017;72:2017-25. [DOI: 10.1111/all.13223] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
74 Ni X, Maiti S, Redko A, Bijani P, Duvic M. Monitoring malignant T-cell clones by direct TCR expression assay in patients with leukemic cutaneous T-cell lymphoma during extracorporeal photopheresis. Photodermatol Photoimmunol Photomed 2021. [PMID: 34543492 DOI: 10.1111/phpp.12732] [Reference Citation Analysis]
75 Trück J, Eugster A, Barennes P, Tipton CM, Luning Prak ET, Bagnara D, Soto C, Sherkow JS, Payne AS, Lefranc MP, Farmer A, Bostick M, Mariotti-Ferrandiz E; AIRR Community. Biological controls for standardization and interpretation of adaptive immune receptor repertoire profiling. Elife 2021;10:e66274. [PMID: 34037521 DOI: 10.7554/eLife.66274] [Reference Citation Analysis]
76 Ghazawi FM, Alghazawi N, Le M, Netchiporouk E, Glassman SJ, Sasseville D, Litvinov IV. Environmental and Other Extrinsic Risk Factors Contributing to the Pathogenesis of Cutaneous T Cell Lymphoma (CTCL). Front Oncol 2019;9:300. [PMID: 31106143 DOI: 10.3389/fonc.2019.00300] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
77 Stadler R. Cancer stem cell - still an enigma in CTCL? Exp Dermatol. 2016; Mar 21. [Epub ahead of print]. [PMID: 26998973 DOI: 10.1111/exd.13017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Lefrançois P, Xie P, Wang L, Tetzlaff MT, Moreau L, Watters AK, Netchiporouk E, Provost N, Gilbert M, Ni X, Sasseville D, Wheeler DA, Duvic M, Litvinov IV. Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients. Oncoimmunology 2018;7:e1467856. [PMID: 30221071 DOI: 10.1080/2162402X.2018.1467856] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
79 Weed J, Girardi M. The difficult--and often delayed--diagnosis of CTCL. Sci Transl Med 2015;7:308fs41. [PMID: 26446952 DOI: 10.1126/scitranslmed.aad2518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
80 Stadler R, Hain C, Cieslak C, Stranzenbach R. Molecular pathogenesis of cutaneous lymphoma-Future directions. Exp Dermatol 2020;29:1062-8. [PMID: 33090576 DOI: 10.1111/exd.14211] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Vermeer MH, Nicolay JP, Scarisbrick JJ, Zinzani PL. The importance of assessing blood tumour burden in cutaneous T-cell lymphoma. Br J Dermatol 2021;185:19-25. [PMID: 33155285 DOI: 10.1111/bjd.19669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Kansal R, Grody WW, Zhou J, Dong L, Li X. The Value of T-Cell Receptor γ (TRG) Clonality Evaluation by Next-Generation Sequencing in Clinical Hematolymphoid Tissues. American Journal of Clinical Pathology 2018;150:193-223. [DOI: 10.1093/ajcp/aqy046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
83 Fujii K, Kanekura T. Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma. Front Med (Lausanne) 2019;6:181. [PMID: 31457014 DOI: 10.3389/fmed.2019.00181] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
84 Miyagaki T. Diagnosis and prognostic stratification of cutaneous lymphoma. J Dermatol 2021. [PMID: 34346516 DOI: 10.1111/1346-8138.16099] [Reference Citation Analysis]
85 Ying Z, Shiue L, Park K, Kollet J, Bijani P, Goswami M, Duvic M, Ni X. Blood transcriptional profiling reveals IL-1 and integrin signaling pathways associated with clinical response to extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma. Oncotarget 2019;10:3183-97. [PMID: 31139332 DOI: 10.18632/oncotarget.26900] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 . Mycosis fungoides. Skin Lymphoma. Wiley; 2020. pp. 23-112. [DOI: 10.1002/9781119485933.ch3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Zimmermann C, Boisson M, Ram-Wolff C, Sadoux A, Louveau B, Vignon-Pennamen MD, Rivet J, Cayuela JM, Dobos G, Moins-Teisserenc H, Roelens M, Gruber A, Lebbé C, Bagot M, Battistella M, Mourah S, de Masson A. Diagnostic performance of high-throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma. Br J Dermatol 2021;185:679-80. [PMID: 33942285 DOI: 10.1111/bjd.20432] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Leiserson MDM, Syrgkanis V, Gilson A, Dudik M, Gillett S, Chayes J, Borgs C, Bajorin DF, Rosenberg JE, Funt S, Snyder A, Mackey L. A multifactorial model of T cell expansion and durable clinical benefit in response to a PD-L1 inhibitor. PLoS One 2018;13:e0208422. [PMID: 30596661 DOI: 10.1371/journal.pone.0208422] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]